AnchorDx
Business Services · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Helix 3rd Road International Biological ...Phone Number
+86 4009300052Website
www.anchordx.comRevenue
$16.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About AnchorDx
Guangzhou Benchmark Medical Co., Ltd. is committed to building a world-class high-throughput sequencing clinical application and research and development platform, and becoming an international leading provider of precision medicine overall solutions.Explore more
AnchorDx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AnchorDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once AnchorDx has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at AnchorDx
Check if AnchorDx has recently received funding, and reach out quickly before it becomes old news!
Check out if AnchorDx is spiking on competitors!
Earning: See what the market has to say on AnchorDx recently announced quarterly report
Product Launch: Get notified when AnchorDx launches new products
AnchorDx, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if AnchorDx had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
AnchorDx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AnchorDx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AnchorDx.
AnchorDx financials insights
Gather financial insights about AnchorDx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series B
$28M
2021
Series C
$40M
AnchorDx Tech Stack
A closer look at the technologies used by AnchorDx
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
New Hire
Executive Move
Funding
Funding
AnchorDx News & Media
AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests
GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing cancer early detection tests, announced today that it has entered into a long-term collaboration with DiaCarta, a precision molecular diagnostics company and developer of novel oncology and infectious disease tests, for product development and global commercialization in the cancer screening area. AnchorDx and DiaCarta will collaborate to develop and commercialize molecular diagnostic products forAnchorDx Enrolls the First Patient For Its UriFind® Bladder Cancer Assay Clinical Trial in the U.S.
GUANGZHOU, China, Nov. 23, 2022 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer early detection solutions, announced the first patient enrollment for the UriFind® bladder cancer assay clinical trial in the U.S., an over 1,000-patient multi-center, prospective testing of the...AnchorDx's Non-invasive Lung Cancer Early Diagnosis Product, PulmoSeek, Completes EU CE Marking Requirements
The company obtained a European Access Permit for in-vitro diagnostics devices (IVDD) authorized by the Netherlands CIBG of Ministry of Health, Welfare and Sport. GUANGZHOU, China, June 15, 2022 /PRNewswire/ -- PulmoSeekTM Lung Cancer Early Detection Assay, the non-invasive blood-based...AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer
GUANGZHOU, China, March 6, 2022 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announce that Dr. Marina Bibikova has come on board as Chief Scientific Officer (CSO). She will be responsible for cancer early detection...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AnchorDx
Sign Up For FreeTo access detailed company insights
Guangzhou Benchmark Medical Co., Ltd. is committed to building a world-class high-throughput sequencing clinical application and research and development platform, and becoming an international leading provider of precision medicine overall solutions.... Read More
